A Study of Tetrathiomolybdate (TM) Plus Capecitabine
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
Recruiting · NCT06134375 · Registry updated 2026-04-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Tetrathiomolybdate (TM) Plus Capecitabine | Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-04-20 | NCT06134375 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Congressionally Directed Medical Research Programs | 87 |
| Dartmouth-Hitchcock Medical Center | 104 |
| National Cancer Institute (NCI) | 3015 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dartmouth Hitchcock Medical Center | Lebanon | United States | 79 |
| Indiana University Simon Cancer Center | Indianapolis | United States | 9 |
| NYU Langone perimutter Cancer Center | New York | United States | 1 |